Pediatric Obesity Care Evolves as GLP-1 Therapy Expands—With Caution

By Gina ShawThe rapid expansion of obesity medications into pediatric care is reshaping treatment frameworks, but not without ethical complexity, said experts at the ASPEN 2026 Nutrition Science & Practice Conference, in Long Beach, California.In 2023, the American Academy of Pediatrics released clinical practice guidelines recommending that clinicians offer obesity pharmacotherapy to adolescents 12 years of age and older as an adjunct to health, behavior, and lifestyle treatment, noted Celt